These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9467955)

  • 21. Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with G alpha(i).
    Mochizuki N; Ohba Y; Kiyokawa E; Kurata T; Murakami T; Ozaki T; Kitabatake A; Nagashima K; Matsuda M
    Nature; 1999 Aug; 400(6747):891-4. PubMed ID: 10476970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
    Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC
    Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator.
    Okazaki M; Kishida S; Hinoi T; Hasegawa T; Tamada M; Kataoka T; Kikuchi A
    Oncogene; 1997 Feb; 14(5):515-21. PubMed ID: 9053849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.
    Piechocki MP; Yoo GH; Dibbley SK; Lonardo F
    Cancer Res; 2007 Jul; 67(14):6825-43. PubMed ID: 17638894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
    Menendez JA; Vellon L; Lupu R
    Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A positive role for PEA3 in HER2-mediated breast tumour progression.
    Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Young LS
    Br J Cancer; 2006 Nov; 95(10):1404-9. PubMed ID: 17060941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms.
    Kurokawa H; Arteaga CL
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):511S-5S. PubMed ID: 12538508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding-induced activation of overexpressed p185HER2 is essential in triggering neuronal differentiation of PC12 cells.
    Orlandi R; Formantici C; Colnaghi MI; Ménard S
    J Cell Biochem; 1997 Dec; 67(3):316-26. PubMed ID: 9361187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas.
    Trimble MS; Xin JH; Guy CT; Muller WJ; Hassell JA
    Oncogene; 1993 Nov; 8(11):3037-42. PubMed ID: 7692372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.
    Lee RJ; Albanese C; Fu M; D'Amico M; Lin B; Watanabe G; Haines GK; Siegel PM; Hung MC; Yarden Y; Horowitz JM; Muller WJ; Pestell RG
    Mol Cell Biol; 2000 Jan; 20(2):672-83. PubMed ID: 10611246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jun amino-terminal kinase 1 activation promotes cell survival in ErbB2-positive breast cancer.
    Han JS; Crowe DL
    Anticancer Res; 2010 Sep; 30(9):3407-12. PubMed ID: 20944115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.
    Shepherd TG; Kockeritz L; Szrajber MR; Muller WJ; Hassell JA
    Curr Biol; 2001 Nov; 11(22):1739-48. PubMed ID: 11719215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.
    Goueli BS; Janknecht R
    Mol Cell Biol; 2004 Jan; 24(1):25-35. PubMed ID: 14673140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells.
    Chen JH; Vercamer C; Li Z; Paulin D; Vandenbunder B; Stehelin D
    Oncogene; 1996 Oct; 13(8):1667-75. PubMed ID: 8895512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through Raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells.
    Höcker M; Henihan RJ; Rosewicz S; Riecken EO; Zhang Z; Koh TJ; Wang TC
    J Biol Chem; 1997 Oct; 272(43):27015-24. PubMed ID: 9341140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
    Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
    DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
    Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
    Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81.
    Bosc DG; Janknecht R
    J Cell Biochem; 2002; 86(1):174-83. PubMed ID: 12112028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The retinoblastoma gene product, Rb, represses neu expression through two regions within the neu regulatory sequence.
    Matin A; Hung MC
    Oncogene; 1994 May; 9(5):1333-9. PubMed ID: 7908732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
    Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
    J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.